Skip to main content
SpringerLink
Log in

Stroke Thrombolysis

The Present Guidelines and Policies for Clinical Use Should Be Changed

  • Chapter
Thrombolytic Therapy for Acute Stroke

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 525 Accesses

Abstract

Although 8 yr have passed since the Food and Drug Administration (FDA) released tissue plasminogen activator (t-PA) for use in the United States to treat patients with acute ischemic stroke, thrombolysis is still very controversial. Clearly, thrombolysis is a step forward but there remain problems with its use, and with the guidelines and policies that direct its application.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams HP, Brott TG, Furlan AJ, et al. Use of thrombolytic drugs. A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for Health Care Professionals from a special writing group of the Stroke Council American Heart Association. Stroke 1996; 27:1711–1718.

    PubMed  Google Scholar 

  2. Quality Standards Subcommittee of the American Academy of Neurology, Practice advisory: Thrombolytic therapy for acute ischemic stroke-summary statement. Neurology 1996;47:835–839.

    Google Scholar 

  3. The National Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.

    Article  Google Scholar 

  4. Caplan LR, Mohr JP, Kistler JP, Koroshetz W. Thrombolysis: not a panacea for ischemic stroke. N Eng J Med 1997;337:1309–1310, 1313.

    Article  CAS  Google Scholar 

  5. Caplan LR. Thrombolysis 2004: the good, the bad, and the ugly. Reviews in Neurological Diseases 2004;1:16–26.

    PubMed  Google Scholar 

  6. Caplan LR. Evidence-based medicine: concerns of a clinical neurologist. J Neurology Neurosurg Psychiatry 2001;71:569–576.

    Article  CAS  Google Scholar 

  7. Caplan LR. Caplan’s Stroke, a clinical approach. Boston: Butterworth-Heinemann, 2000, pp. 119–169.

    Google Scholar 

  8. Caplan LR. The case against the present guidelines for stroke thrombolysis. In: Thrombolytic Therapy for Stroke, 1st Ed., Lyden PD ed. Totowa, NJ: Humana Press, 2001, pp.223–235.

    Google Scholar 

  9. Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke 1989;20:473–476.

    PubMed  CAS  Google Scholar 

  10. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from tPA therapy? Neurology 2001;56:1015–1020.

    PubMed  CAS  Google Scholar 

  11. Fink JN, Kumar S, Horkan C, et al. The stroke patient who woke up. Clinical and radiological features including diffusion and perfusion MRI. Stroke 2002;33:988–993.

    Article  PubMed  Google Scholar 

  12. Warach S. New imaging strategies for patients selection for thrombolytic and neuroprotective strategies. Neurology 2001; 57(Suppl 2):S48–S52.

    PubMed  CAS  Google Scholar 

  13. von Kummer R, Weber J. Brain and vascular imaging in acute ischemic stroke: the potential of computed tomography. Neurology 1997;49(Suppl 4):S52–S55.

    Google Scholar 

  14. Lee KH, Cho S-J, Byun HS, et al. Triphasic perfusion computed tomography in acute middle cerebral artery stroke. A correlation with angiographic findings. Arch Neurol 2000;57:990–999.

    Article  PubMed  CAS  Google Scholar 

  15. Fisher M, Prichard JW, Warach S. New magnetic resonance techniques for acute ischemic stroke. JAMA 1995;274:908–911.

    Article  PubMed  CAS  Google Scholar 

  16. Staroselskaya I, Chaves C, Silver B, et al. Relationship between magnetic resonance arterial patency and perfusion-diffusion mismatch in acute ischemic stroke and its potential clinical use. Arch Neurol 2001;58:1069–1074.

    Article  PubMed  CAS  Google Scholar 

  17. Wintermark M, Reichhart M, Thiran J-P, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417–432.

    Article  PubMed  Google Scholar 

  18. Nabavi DG, Kloska SP, Nam E-M, et al. MOSAIC: multimodal stroke assessment using computed tomography. Novel diagnostic approach for the prediction of infarction size and clinical outcome. Stroke 2002;33: 2819–2826.

    Article  PubMed  Google Scholar 

  19. Linfante I, Llinas R, Schlaug G, Chaves C, Warach S, Caplan LR. Diffusion-weighted imaging and NIH Stroke Scale in the acute phase of posterior circulation stroke. Arch Neurol 2001;58:621–628.

    Article  PubMed  CAS  Google Scholar 

  20. Selim MH, Kumar S, Fink Jn, Schlaug G, Caplan LR, Linfante I. Seizures at stroke onset: should it be an absolute contraindication to thrombolysis. Cerebrovasc Dis 2002;14:54–57.

    Article  PubMed  Google Scholar 

  21. Ropper AH. “Convulsions” in basilar artery occlusion. Neurology 1988;38: 1500–1501.

    PubMed  CAS  Google Scholar 

  22. Saposnik G, Caplan LR. Convulsive-like movements in brainstem stroke. Arch Neurol 2000;58: 654–657.

    Article  Google Scholar 

  23. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4–11.

    PubMed  Google Scholar 

  24. Furlan AJ, Higashida RT, Wechsler L, et al. A randomized trial of intra-arterial pro-urokinase for acute ischemic stroke of less than 6 hours duration due to middle cerebral artery occlusion. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282: 2003–2011.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology Department, Beth Israel Deaconess Medical Center, Boston, MA

    Louis R. Caplan MD

Authors
  1. Louis R. Caplan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. USCD Stroke Center, University of California, San Diego

    Patrick D. Lyden MD

  2. Veteran’s Affairs Medical Center, San Diego, CA

    Patrick D. Lyden MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Caplan, L.R. (2005). Stroke Thrombolysis. In: Lyden, P.D. (eds) Thrombolytic Therapy for Acute Stroke. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-933-8:223

Download citation

  • DOI: https://doi.org/10.1385/1-59259-933-8:223

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-398-5

  • Online ISBN: 978-1-59259-933-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation